世界の代謝障害治療薬市場インサイト2021：企業別、地域別、種類別、用途別

• 英文タイトル：Metabolic Disorders Drugs Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type

• レポートコード：MRC21PRO080881 • 出版社/出版日：Prof Research / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（納期：3日） • 産業分類：製薬

• 販売価格（消費税別）

Single User	￥473,600 (USD3,200)	▷ お問い合わせ
Site License	￥621,600 (USD4,200)	▷ お問い合わせ
Global Site License	￥769,600 (USD5,200)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本市場調査資料では、代謝障害治療薬のグローバル市場について調査・分析し、代謝障害治療薬のグローバル市場概要、市場動向、産業構造、貿易動向（輸出・輸入）、地域別市場規模（北米、南米、アジア、ヨーロッパ、中東・アフリカ）、世界の市場規模予測、セグメント別分析（種類別（錠剤、注射）、用途別（糖尿病、甲状腺・下垂体障害、その他））、主要ベンダー分析などの情報をお届け致します。 ・エグゼクティブサマリー ・市場概要 ・市場動向分析 ・産業構造分析 ・貿易動向（輸出・輸入） ・代謝障害治療薬の北米市場規模・分析 ・代謝障害治療薬の南米市場規模・分析 ・代謝障害治療薬のアジア太平洋市場規模・分析 ・代謝障害治療薬のヨーロッパ市場規模・分析 ・代謝障害治療薬の中東・アフリカ市場規模・分析 ・代謝障害治療薬の世界市場規模予測 ・セグメント別分析：種類別（錠剤、注射）、用途別（糖尿病、甲状腺・下垂体障害、その他） ・主要ベンダー分析

This report describes the global market size of Metabolic Disorders Drugs from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026.

For geography segment, regional supply, demand, major players, price is presented from 2016 to 2026. This report cover following regions:
North America
South America
Asia & Pacific
Europe
MEA

The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For competitor segment, the report include global key players of Metabolic Disorders Drugs as well as some small players. The information for each competitor include:
Company Profile
Main Business Information
SWOT Analysis
Sales, Revenue, Price and Gross Margin
Market Share

Applications Segment:
Diabetes
Disorders of the Thyroid and Pituitary Gland
Other

Types Segment:
Tablet
Injection

Companies Covered:
Zealand Pharma
Rhythm
OxThera
Biophytis
Biophytis
Zafgen
PerkinElmer
Eternygen
Pronutria Biosciences
MedGenome
CellCentric
Nimbus Therapeutics
Mitobridge
etc.

Please ask for sample pages for full companies list

Base Year: 2021
Historical Data: from 2016 to 2020
Forecast Data: from 2021 to 2026

Any special requirements about this report, please let us know and we can provide custom report.

レポート目次

---

Table of Contents
CHAPTER 1 EXECUTIVE SUMMARY
CHAPTER 2 ABBREVIATION AND ACRONYMS
CHAPTER 3 PREFACE
3.1 RESEARCH SCOPE
3.2 RESEARCH SOURCES
3.2.1 Data Sources
3.2.2 Assumptions
3.3 RESEARCH METHOD
CHAPTER 4 MARKET LANDSCAPE
4.1 MARKET OVERVIEW
4.2 CLASSIFICATION/TYPES
4.3 APPLICATION/END USERS
CHAPTER 5 MARKET TREND ANALYSIS
5.1 INTRODUCTION
5.2 DRIVERS
5.3 RESTRAINTS
5.4 OPPORTUNITIES
5.5 THREATS
CHAPTER 6 INDUSTRY CHAIN ANALYSIS
6.1 UPSTREAM/SUPPLIERS ANALYSIS
6.2 Metabolic Disorders Drugs ANALYSIS
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 DOWNSTREAM BUYERS/END USERS
CHAPTER 7 LATEST MARKET DYNAMICS
7.1 LATEST NEWS
7.2 MERGER AND ACQUISITION
7.3 PLANNED/FUTURE PROJECT
7.4 POLICY DYNAMICS
CHAPTER 8 TRADING ANALYSIS
8.1 EXPORT OF Metabolic Disorders Drugs BY REGION
8.2 IMPORT OF Metabolic Disorders Drugs BY REGION
8.3 BALANCE OF TRADE
CHAPTER 9 HISTORICAL AND FORECAST Metabolic Disorders Drugs MARKET IN NORTH AMERICA (2016-2026)
9.1 Metabolic Disorders Drugs MARKET SIZE
9.2 Metabolic Disorders Drugs DEMAND BY END USE
9.3 COMPETITION BY PLAYERS/SUPPLIERS
9.4 TYPE SEGMENTATION AND PRICE
9.5 KEY COUNTRIES ANALYSIS
9.5.1 US
9.5.2 Canada
9.5.3 Mexico
CHAPTER 10 HISTORICAL AND FORECAST Metabolic Disorders Drugs MARKET IN SOUTH AMERICA (2016-2026)
10.1 Metabolic Disorders Drugs MARKET SIZE
10.2 Metabolic Disorders Drugs DEMAND BY END USE
10.3 COMPETITION BY PLAYERS/SUPPLIERS
10.4 TYPE SEGMENTATION AND PRICE
10.5 KEY COUNTRIES ANALYSIS
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Chile
10.5.4 Peru
CHAPTER 11 HISTORICAL AND FORECAST Metabolic Disorders Drugs MARKET IN ASIA & PACIFIC (2016-2026)
11.1 Metabolic Disorders Drugs MARKET SIZE
11.2 Metabolic Disorders Drugs DEMAND BY END USE
11.3 COMPETITION BY PLAYERS/SUPPLIERS
11.4 TYPE SEGMENTATION AND PRICE
11.5 KEY COUNTRIES ANALYSIS
11.5.1 China
11.5.2 India
11.5.3 Japan
11.5.4 South Korea
11.5.5 ASEAN
11.5.6 Australia
CHAPTER 12 HISTORICAL AND FORECAST Metabolic Disorders Drugs MARKET IN EUROPE (2016-2026)
12.1 Metabolic Disorders Drugs MARKET SIZE
12.2 Metabolic Disorders Drugs DEMAND BY END USE
12.3 COMPETITION BY PLAYERS/SUPPLIERS
12.4 TYPE SEGMENTATION AND PRICE
12.5 KEY COUNTRIES ANALYSIS
12.5.1 Germany
12.5.2 France
12.5.3 UK
12.5.4 Italy
12.5.5 Spain
12.5.6 Belgium
12.5.7 Netherlands
12.5.8 Austria
12.5.9 Poland
12.5.10 Russia
CHAPTER 13 HISTORICAL AND FORECAST Metabolic Disorders Drugs MARKET IN MEA (2016-2026)
13.1 Metabolic Disorders Drugs MARKET SIZE
13.2 Metabolic Disorders Drugs DEMAND BY END USE
13.3 COMPETITION BY PLAYERS/SUPPLIERS
13.4 TYPE SEGMENTATION AND PRICE
13.5 KEY COUNTRIES ANALYSIS
13.5.1 Egypt
13.5.2 Israel
13.5.3 South Africa
13.5.4 GCC
13.5.5 Turkey
CHAPTER 14 SUMMARY FOR GLOBAL Metabolic Disorders Drugs MARKET (2016-2021)
14.1 Metabolic Disorders Drugs MARKET SIZE
14.2 Metabolic Disorders Drugs DEMAND BY END USE
14.3 COMPETITION BY PLAYERS/SUPPLIERS
14.4 TYPE SEGMENTATION AND PRICE
CHAPTER 15 GLOBAL Metabolic Disorders Drugs MARKET FORECAST (2021-2026)
15.1 Metabolic Disorders Drugs MARKET SIZE FORECAST
15.2 Metabolic Disorders Drugs DEMAND FORECAST
15.3 COMPETITION BY PLAYERS/SUPPLIERS
15.4 TYPE SEGMENTATION AND PRICE FORECAST
CHAPTER 16 ANALYSIS OF GLOBAL KEY VENDORS
16.1 Zealand Pharma
16.1.1 Company Profile
16.1.2 Main Business and Metabolic Disorders Drugs Information
16.1.3 SWOT Analysis of Zealand Pharma
16.1.4 Zealand Pharma Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
16.2 Rhythm
16.2.1 Company Profile
16.2.2 Main Business and Metabolic Disorders Drugs Information
16.2.3 SWOT Analysis of Rhythm
16.2.4 Rhythm Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
16.3 OxThera
16.3.1 Company Profile
16.3.2 Main Business and Metabolic Disorders Drugs Information
16.3.3 SWOT Analysis of OxThera
16.3.4 OxThera Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
16.4 Biophytis
16.4.1 Company Profile
16.4.2 Main Business and Metabolic Disorders Drugs Information
16.4.3 SWOT Analysis of Biophytis
16.4.4 Biophytis Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
16.5 Biophytis
16.5.1 Company Profile
16.5.2 Main Business and Metabolic Disorders Drugs Information
16.5.3 SWOT Analysis of Biophytis
16.5.4 Biophytis Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
16.6 Zafgen
16.6.1 Company Profile
16.6.2 Main Business and Metabolic Disorders Drugs Information
16.6.3 SWOT Analysis of Zafgen
16.6.4 Zafgen Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
16.7 PerkinElmer
16.7.1 Company Profile
16.7.2 Main Business and Metabolic Disorders Drugs Information
16.7.3 SWOT Analysis of PerkinElmer
16.7.4 PerkinElmer Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
16.8 Eternygen
16.8.1 Company Profile
16.8.2 Main Business and Metabolic Disorders Drugs Information
16.8.3 SWOT Analysis of Eternygen
16.8.4 Eternygen Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
16.9 Pronutria Biosciences
16.9.1 Company Profile
16.9.2 Main Business and Metabolic Disorders Drugs Information
16.9.3 SWOT Analysis of Pronutria Biosciences
16.9.4 Pronutria Biosciences Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
16.10 MedGenome
16.10.1 Company Profile
16.10.2 Main Business and Metabolic Disorders Drugs Information
16.10.3 SWOT Analysis of MedGenome
16.10.4 MedGenome Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
16.11 CellCentric
16.11.1 Company Profile
16.11.2 Main Business and Metabolic Disorders Drugs Information
16.11.3 SWOT Analysis of CellCentric
16.11.4 CellCentric Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
16.12 Nimbus Therapeutics
16.12.1 Company Profile
16.12.2 Main Business and Metabolic Disorders Drugs Information
16.12.3 SWOT Analysis of Nimbus Therapeutics
16.12.4 Nimbus Therapeutics Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
16.13 Mitobridge
16.13.1 Company Profile
16.13.2 Main Business and Metabolic Disorders Drugs Information
16.13.3 SWOT Analysis of Mitobridge
16.13.4 Mitobridge Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
……

TABLES AND FIGURES
Table Abbreviation and Acronyms List
Table Research Scope of Metabolic Disorders Drugs Report
Table Data Sources of Metabolic Disorders Drugs Report
Table Major Assumptions of Metabolic Disorders Drugs Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Metabolic Disorders Drugs Picture
Table Metabolic Disorders Drugs Classification
Table Metabolic Disorders Drugs Applications List
Table Drivers of Metabolic Disorders Drugs Market
Table Restraints of Metabolic Disorders Drugs Market
Table Opportunities of Metabolic Disorders Drugs Market
Table Threats of Metabolic Disorders Drugs Market
Table Raw Materials Suppliers List
Table Different Production Methods of Metabolic Disorders Drugs
Table Cost Structure Analysis of Metabolic Disorders Drugs
Table Key End Users List
Table Latest News of Metabolic Disorders Drugs Market
Table Merger and Acquisition List
Table Planned/Future Project of Metabolic Disorders Drugs Market
Table Policy of Metabolic Disorders Drugs Market
Table 2016-2026 Regional Export of Metabolic Disorders Drugs
Table 2016-2026 Regional Import of Metabolic Disorders Drugs
Table 2016-2026 Regional Trade Balance
Figure 2016-2026 Regional Trade Balance
Table 2016-2026 North America Metabolic Disorders Drugs Market Size and Market Volume List
Figure 2016-2026 North America Metabolic Disorders Drugs Market Size and CAGR
Figure 2016-2026 North America Metabolic Disorders Drugs Market Volume and CAGR
Table 2016-2026 North America Metabolic Disorders Drugs Demand List by Application
Table 2016-2021 North America Metabolic Disorders Drugs Key Players Sales List
Table 2016-2021 North America Metabolic Disorders Drugs Key Players Market Share List
Table 2016-2026 North America Metabolic Disorders Drugs Demand List by Type
Table 2016-2021 North America Metabolic Disorders Drugs Price List by Type
Table 2016-2026 US Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 US Metabolic Disorders Drugs Import & Export List
Table 2016-2026 Canada Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Canada Metabolic Disorders Drugs Import & Export List
Table 2016-2026 Mexico Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Mexico Metabolic Disorders Drugs Import & Export List
Table 2016-2026 South America Metabolic Disorders Drugs Market Size and Market Volume List
Figure 2016-2026 South America Metabolic Disorders Drugs Market Size and CAGR
Figure 2016-2026 South America Metabolic Disorders Drugs Market Volume and CAGR
Table 2016-2026 South America Metabolic Disorders Drugs Demand List by Application
Table 2016-2021 South America Metabolic Disorders Drugs Key Players Sales List
Table 2016-2021 South America Metabolic Disorders Drugs Key Players Market Share List
Table 2016-2026 South America Metabolic Disorders Drugs Demand List by Type
Table 2016-2021 South America Metabolic Disorders Drugs Price List by Type
Table 2016-2026 Brazil Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Brazil Metabolic Disorders Drugs Import & Export List
Table 2016-2026 Argentina Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Argentina Metabolic Disorders Drugs Import & Export List
Table 2016-2026 Chile Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Chile Metabolic Disorders Drugs Import & Export List
Table 2016-2026 Peru Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Peru Metabolic Disorders Drugs Import & Export List
Table 2016-2026 Asia & Pacific Metabolic Disorders Drugs Market Size and Market Volume List
Figure 2016-2026 Asia & Pacific Metabolic Disorders Drugs Market Size and CAGR
Figure 2016-2026 Asia & Pacific Metabolic Disorders Drugs Market Volume and CAGR
Table 2016-2026 Asia & Pacific Metabolic Disorders Drugs Demand List by Application
Table 2016-2021 Asia & Pacific Metabolic Disorders Drugs Key Players Sales List
Table 2016-2021 Asia & Pacific Metabolic Disorders Drugs Key Players Market Share List
Table 2016-2026 Asia & Pacific Metabolic Disorders Drugs Demand List by Type
Table 2016-2021 Asia & Pacific Metabolic Disorders Drugs Price List by Type
Table 2016-2026 China Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 China Metabolic Disorders Drugs Import & Export List
Table 2016-2026 India Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 India Metabolic Disorders Drugs Import & Export List
Table 2016-2026 Japan Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Japan Metabolic Disorders Drugs Import & Export List
Table 2016-2026 South Korea Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 South Korea Metabolic Disorders Drugs Import & Export List
Table 2016-2026 ASEAN Metabolic Disorders Drugs Market Size List
Table 2016-2026 ASEAN Metabolic Disorders Drugs Market Volume List
Table 2016-2026 ASEAN Metabolic Disorders Drugs Import List
Table 2016-2026 ASEAN Metabolic Disorders Drugs Export List
Table 2016-2026 Australia Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Australia Metabolic Disorders Drugs Import & Export List
Table 2016-2026 Europe Metabolic Disorders Drugs Market Size and Market Volume List
Figure 2016-2026 Europe Metabolic Disorders Drugs Market Size and CAGR
Figure 2016-2026 Europe Metabolic Disorders Drugs Market Volume and CAGR
Table 2016-2026 Europe Metabolic Disorders Drugs Demand List by Application
Table 2016-2021 Europe Metabolic Disorders Drugs Key Players Sales List
Table 2016-2021 Europe Metabolic Disorders Drugs Key Players Market Share List
Table 2016-2026 Europe Metabolic Disorders Drugs Demand List by Type
Table 2016-2021 Europe Metabolic Disorders Drugs Price List by Type
Table 2016-2026 Germany Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Germany Metabolic Disorders Drugs Import & Export List
Table 2016-2026 France Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 France Metabolic Disorders Drugs Import & Export List
Table 2016-2026 UK Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 UK Metabolic Disorders Drugs Import & Export List
Table 2016-2026 Italy Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Italy Metabolic Disorders Drugs Import & Export List
Table 2016-2026 Spain Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Spain Metabolic Disorders Drugs Import & Export List
Table 2016-2026 Belgium Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Belgium Metabolic Disorders Drugs Import & Export List
Table 2016-2026 Netherlands Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Netherlands Metabolic Disorders Drugs Import & Export List
Table 2016-2026 Austria Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Austria Metabolic Disorders Drugs Import & Export List
Table 2016-2026 Poland Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Poland Metabolic Disorders Drugs Import & Export List
Table 2016-2026 Russia Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Russia Metabolic Disorders Drugs Import & Export List
Table 2016-2026 MEA Metabolic Disorders Drugs Market Size and Market Volume List
Figure 2016-2026 MEA Metabolic Disorders Drugs Market Size and CAGR
Figure 2016-2026 MEA Metabolic Disorders Drugs Market Volume and CAGR
Table 2016-2026 MEA Metabolic Disorders Drugs Demand List by Application
Table 2016-2021 MEA Metabolic Disorders Drugs Key Players Sales List
Table 2016-2021 MEA Metabolic Disorders Drugs Key Players Market Share List
Table 2016-2026 MEA Metabolic Disorders Drugs Demand List by Type
Table 2016-2021 MEA Metabolic Disorders Drugs Price List by Type
Table 2016-2026 Egypt Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Egypt Metabolic Disorders Drugs Import & Export List
Table 2016-2026 Israel Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Israel Metabolic Disorders Drugs Import & Export List
Table 2016-2026 South Africa Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 South Africa Metabolic Disorders Drugs Import & Export List
Table 2016-2026 GCC Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 GCC Metabolic Disorders Drugs Import & Export List
Table 2016-2026 Turkey Metabolic Disorders Drugs Market Size and Market Volume List
Table 2016-2026 Turkey Metabolic Disorders Drugs Import & Export List
Table 2016-2021 Global Metabolic Disorders Drugs Market Size List by Region
Table 2016-2021 Global Metabolic Disorders Drugs Market Size Share List by Region
Table 2016-2021 Global Metabolic Disorders Drugs Market Volume List by Region
Table 2016-2021 Global Metabolic Disorders Drugs Market Volume Share List by Region
Table 2016-2021 Global Metabolic Disorders Drugs Demand List by Application
Table 2016-2021 Global Metabolic Disorders Drugs Demand Market Share List by Application
Table 2016-2021 Global Metabolic Disorders Drugs Capacity List
Table 2016-2021 Global Metabolic Disorders Drugs Key Vendors Capacity Share List
Table 2016-2021 Global Metabolic Disorders Drugs Key Vendors Production List
Table 2016-2021 Global Metabolic Disorders Drugs Key Vendors Production Share List
Figure 2016-2021 Global Metabolic Disorders Drugs Capacity Production and Growth Rate
Table 2016-2021 Global Metabolic Disorders Drugs Key Vendors Production Value List
Figure 2016-2021 Global Metabolic Disorders Drugs Production Value and Growth Rate
Table 2016-2021 Global Metabolic Disorders Drugs Key Vendors Production Value Share List
Table 2016-2021 Global Metabolic Disorders Drugs Demand List by Type
Table 2016-2021 Global Metabolic Disorders Drugs Demand Market Share List by Type
Table 2016-2021 Regional Metabolic Disorders Drugs Price List
Table 2021-2026 Global Metabolic Disorders Drugs Market Size List by Region
Table 2021-2026 Global Metabolic Disorders Drugs Market Size Share List by Region
Table 2021-2026 Global Metabolic Disorders Drugs Market Volume List by Region
Table 2021-2026 Global Metabolic Disorders Drugs Market Volume Share List by Region
Table 2021-2026 Global Metabolic Disorders Drugs Demand List by Application
Table 2021-2026 Global Metabolic Disorders Drugs Demand Market Share List by Application
Table 2021-2026 Global Metabolic Disorders Drugs Capacity List
Table 2021-2026 Global Metabolic Disorders Drugs Key Vendors Capacity Share List
Table 2021-2026 Global Metabolic Disorders Drugs Key Vendors Production List
Table 2021-2026 Global Metabolic Disorders Drugs Key Vendors Production Share List
Figure 2021-2026 Global Metabolic Disorders Drugs Capacity Production and Growth Rate
Table 2021-2026 Global Metabolic Disorders Drugs Key Vendors Production Value List
Figure 2021-2026 Global Metabolic Disorders Drugs Production Value and Growth Rate
Table 2021-2026 Global Metabolic Disorders Drugs Key Vendors Production Value Share List
Table 2021-2026 Global Metabolic Disorders Drugs Demand List by Type
Table 2021-2026 Global Metabolic Disorders Drugs Demand Market Share List by Type
Table 2021-2026 Regional Metabolic Disorders Drugs Price List
Table Zealand Pharma Information List
Table SWOT Analysis of Zealand Pharma
Table 2016-2021 Zealand Pharma Metabolic Disorders Drugs Product Capacity Production Price Cost Production Value List
Figure 2016-2021 Zealand Pharma Metabolic Disorders Drugs Capacity Production and Growth Rate
Table Rhythm Information List
Table SWOT Analysis of Rhythm
Table 2016-2021 Rhythm Metabolic Disorders Drugs Product Capacity Production Price Cost Production Value List
Figure 2016-2021 Rhythm Metabolic Disorders Drugs Capacity Production and Growth Rate
Table OxThera Information List
Table SWOT Analysis of OxThera
Table 2016-2021 OxThera Metabolic Disorders Drugs Product Capacity Production Price Cost Production Value List
Figure 2016-2021 OxThera Metabolic Disorders Drugs Capacity Production and Growth Rate
Table Biophytis Information List
Table SWOT Analysis of Biophytis
Table 2016-2021 Biophytis Metabolic Disorders Drugs Product Capacity Production Price Cost Production Value List
Figure 2016-2021 Biophytis Metabolic Disorders Drugs Capacity Production and Growth Rate
Table Biophytis Information List
Table SWOT Analysis of Biophytis
Table 2016-2021 Biophytis Metabolic Disorders Drugs Product Capacity Production Price Cost Production Value List
Figure 2016-2021 Biophytis Metabolic Disorders Drugs Capacity Production and Growth Rate
Table Zafgen Information List
Table SWOT Analysis of Zafgen
Table 2016-2021 Zafgen Metabolic Disorders Drugs Product Capacity Production Price Cost Production Value List
Figure 2016-2021 Zafgen Metabolic Disorders Drugs Capacity Production and Growth Rate
Table PerkinElmer Information List
Table SWOT Analysis of PerkinElmer
Table 2016-2021 PerkinElmer Metabolic Disorders Drugs Product Capacity Production Price Cost Production Value List
Figure 2016-2021 PerkinElmer Metabolic Disorders Drugs Capacity Production and Growth Rate
Table Eternygen Information List
Table SWOT Analysis of Eternygen
Table 2016-2021 Eternygen Metabolic Disorders Drugs Product Capacity Production Price Cost Production Value List
Figure 2016-2021 Eternygen Metabolic Disorders Drugs Capacity Production and Growth Rate
Table Pronutria Biosciences Information List
Table SWOT Analysis of Pronutria Biosciences
Table 2016-2021 Pronutria Biosciences Metabolic Disorders Drugs Product Capacity Production Price Cost Production Value List
Figure 2016-2021 Pronutria Biosciences Metabolic Disorders Drugs Capacity Production and Growth Rate
Table MedGenome Information List
Table SWOT Analysis of MedGenome
Table 2016-2021 MedGenome Metabolic Disorders Drugs Product Capacity Production Price Cost Production Value List
Figure 2016-2021 MedGenome Metabolic Disorders Drugs Capacity Production and Growth Rate
Table CellCentric Information List
Table SWOT Analysis of CellCentric
Table 2016-2021 CellCentric Metabolic Disorders Drugs Product Capacity Production Price Cost Production Value List
Figure 2016-2021 CellCentric Metabolic Disorders Drugs Capacity Production and Growth Rate
Table Nimbus Therapeutics Information List
Table SWOT Analysis of Nimbus Therapeutics
Table 2016-2021 Nimbus Therapeutics Metabolic Disorders Drugs Product Capacity Production Price Cost Production Value List
Figure 2016-2021 Nimbus Therapeutics Metabolic Disorders Drugs Capacity Production and Growth Rate
Table Mitobridge Information List
Table SWOT Analysis of Mitobridge
Table 2016-2021 Mitobridge Metabolic Disorders Drugs Product Capacity Production Price Cost Production Value List
Figure 2016-2021 Mitobridge Metabolic Disorders Drugs Capacity Production and Growth Rate
……

---